Karen Flynn - Jul 26, 2021 Form 4 Insider Report for Catalent, Inc. (CTLT)

Role
Pres. Biologics & CCO
Signature
/s/ Jose Ibietatorremendia, attorney-in-fact
Stock symbol
CTLT
Transactions as of
Jul 26, 2021
Transactions value $
$0
Form type
4
Date filed
7/28/2021, 04:26 PM
Next filing
Jan 11, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CTLT Common Stock Award $0 +1.15K +3.33% $0.00 35.7K Jul 26, 2021 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CTLT Options to purchase Common Stock Award $0 +5.95K $0.00 5.95K Jul 26, 2021 Common Stock 5.95K $113.00 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units (RSUs) received by the reporting person pursuant to the Issuer's annual grant to executive officers and other personnel under its long-term incentive plan. Each RSU represents the right to receive one share of the Issuer's common stock as of the date of vesting, which will occur three (3) years from the date of award.
F2 Includes restricted stock units.
F3 Received by the reporting person pursuant to the Issuer's annual grant to executive officers and other personnel under its long-term incentive plan.
F4 The options vest and become exercisable in four equal annual installments beginning on July 26, 2022.